Safety Study of a Recombinant Protein Vaccine to Treat Esophageal Cancer
Clinical trial NCT01003808 · COMPLETED
Trial details
- NCT number
- NCT01003808
- Sponsor
- ImmunoFrontier, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2012-03-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.